The present disclosure describes a treated cellulosic material comprising: a cellulosic material having a porous structure defining a plurality of pores, at least a portion of the pores containing a treating agent comprising: a polymer comprising an olefin-carboxylic acid copolymer; and a modifying agent comprising a hydrophobic amine.

The present disclosure describes a treated cellulosic material comprising: a cellulosic material having a porous structure defining a plurality of pores, at least a portion of the pores containing a treating agent comprising: a polymer comprising an olefin-carboxylic acid copolymer; and a modifying agent comprising a hydrophobic amine.

The present invention relates to the use of compounds of the invention for treatment and/or prevention of fatigue, including fatigue associated with diseases or treatments.

An antimicrobial system comprising (a) an antimicrobial compound according to Formula I (I) and (b) a stabilised chlorine compound, wherein the compounds are separate compounds or comprise a unitary composition; wherein R1, R2 and R3 independently represent a hydrogen atom; halogen atom; hydroxy group; amino group; alkylamino group, alkyl group, hydroxyalkyl group, acyl group, haloalkyl group or alkoxy group having 1 to 4 carbon atoms; or an acylamido group having 1 to 10 carbon atoms; and A represents 2-thiazolamine; 2-propenenitrile; 2-propenoic acid; alkyl ester or hydroxyalkyl ester of 2-propenoic acid having 1 to 4 carbon atoms; or CHCHCONR5R6 group, where R5 and R6 represent independently hydrogen atom, alkyl or hydroxyalkyl having 1 to 4 carbon atoms; and wherein the stabilised chlorine compound comprises the reaction product of a reaction between active chlorine and a nitrogenous reactant selected from ammonium, urea, carbamate and dimethylhydantoin.

##STR00001##

An antimicrobial system comprising (a) an antimicrobial compound according to Formula I (I) and (b) a stabilised chlorine compound, wherein the compounds are separate compounds or comprise a unitary composition; wherein R1, R2 and R3 independently represent a hydrogen atom; halogen atom; hydroxy group; amino group; alkylamino group, alkyl group, hydroxyalkyl group, acyl group, haloalkyl group or alkoxy group having 1 to 4 carbon atoms; or an acylamido group having 1 to 10 carbon atoms; and A represents 2-thiazolamine; 2-propenenitrile; 2-propenoic acid; alkyl ester or hydroxyalkyl ester of 2-propenoic acid having 1 to 4 carbon atoms; or CHCHCONR5R6 group, where R5 and R6 represent independently hydrogen atom, alkyl or hydroxyalkyl having 1 to 4 carbon atoms; and wherein the stabilised chlorine compound comprises the reaction product of a reaction between active chlorine and a nitrogenous reactant selected from ammonium, urea, carbamate and dimethylhydantoin.

##STR00001##

This disclosure relates to methods of regulating growth in a plant. Specifically, the methods of the disclosure regulate growth of the plant by administration of a composition comprising an effective amount of one or more apocarotenoids to the plant, its part, or the seed.

This disclosure relates to methods of regulating growth in a plant. Specifically, the methods of the disclosure regulate growth of the plant by administration of a composition comprising an effective amount of one or more apocarotenoids to the plant, its part, or the seed.

A hydrophilic polymer matrix wherein the polymer matrix comprises one or more monomers or polymers selected from the group consisting of Diglycidyl Ethers, Polyacrylamides, Polyvinyls, Polysaccharides, Polyesters, Esters, Polyethylene Glycols, Polypropylene Glycols, Butanediols, Epoxides or other hydrophilic polymers that are crosslinked to form a flexible non-soluble polymer matrix that has more than one excess or unreacted molecule and wherein excess molecules are available or have electrons available for one or more charge coupling or bonding reactions that are reversible, with one or more target molecules such as but not limited to salts, chlorides, acids and or ion species solvated in water or other solvent.

A hydrophilic polymer matrix wherein the polymer matrix comprises one or more monomers or polymers selected from the group consisting of Diglycidyl Ethers, Polyacrylamides, Polyvinyls, Polysaccharides, Polyesters, Esters, Polyethylene Glycols, Polypropylene Glycols, Butanediols, Epoxides or other hydrophilic polymers that are crosslinked to form a flexible non-soluble polymer matrix that has more than one excess or unreacted molecule and wherein excess molecules are available or have electrons available for one or more charge coupling or bonding reactions that are reversible, with one or more target molecules such as but not limited to salts, chlorides, acids and or ion species solvated in water or other solvent.

The invention relates to methods and compositions for the treatment or prevention of diseases and disorders associated with myeloproliferative disorders. In particular, the invention relates to an LSD 1 inhibitor for use in treating or preventing Philadelphia chromosome negative myeloproliferative disorders.